We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Eric Falcand has over 30 years’ experience in the pharmaceutical industry in commercialization, general management, business development & alliance management. After early years in commercial operations at Virbac and Synthelabo (now Sanofi), he joined the 2nd French pharmaceutical group Servier in 1997 where he gained general management experience in heading the organization in Russia and then becoming CEO in the UK, after which he took the responsibility of US partnerships and licenses back at Head Office in Paris. Joining the newly created Business Development team in 2011, Eric has been actively involved or been the lead negotiator of all major agreements signed by Servier with Academia, Biotechs or Pharmas; he is credited for having built and consolidated the Alliance Management capabilities within Servier in 2013. He was appointed Vice-President, Head of Business Development & Licensing for the Servier Group in August 2015.
This speaker's sessions: